University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Stanton A. Glantz, PhD

Stanton A. Glantz, PhD

Professor, Department of Medicine; and Director, Center for Tobacco Control Research and Education, UCSF; Co-Leader, Tobacco Control Program, UCSF Helen Diller Family Comprehensive Cancer Center
American Legacy Foundation Distinguished Professorship in Tobacco Control, UCSF

Cancer Center Program Memberships

Tobacco Control

Research Summary

I am a widely recognized researcher with a reputation for identifying and pursuing high-impact questions that make practical contributions to tobacco control policy development, evaluation, and implementation. I am skilled in both qualitative and quantitative research methods, having written several books on tobacco control policy and two successful statistics textbooks. As Director of the UCSF Center for Tobacco Control Research and Education (CTCRE), I have extensive practical experience in developing and managing transdisciplinary academic programs and bringing together faculty from many disciplines. I have supervised a total of 96 fellows and graduate students during my career and am the Program Director of the CTCRE Postdoctoral Training Program in collaboration with Dr. Pamela Ling. I have published in a broad range of tobacco control areas, including economic models of the effects of tobacco control policies on health outcomes and health care costs, social and environmental determinants of smoking and smoking cessation, young adult smoking, and health effects of secondhand smoke, particularly on heart disease. I wrote the first papers based on analyses of previously secret tobacco industry documents (published in JAMA in 1995). Since then, I have worked with the UCSF Library to build the Legacy Tobacco Documents Library, which now exceeds 83 million pages (and is growing). The library is a major international research resource that has supported preparation of over 900 publications, including 134 authored by me, and the CTCRE is an internationally known training resource for tobacco document research that serves postdoctoral fellows and many others working in tobacco control. I am also the Principal Investigator of the UCSF Tobacco Center of Regulatory Science (TCORS), which brings together a broad multidisciplinary group of faculty and provides training opportunities and funds for pilot studies for trainees with an interest in tobacco regulatory science.


University of Cincinnati, OH, BS, 1969, Aerospace Engineering
Stanford University, CA, MS, 1970, Applied Mechanics
Stanford University, CA, PhD, 1973, Applied Mechanics and Engineering Economic Systems
Stanford University, CA, Postdoc, 1975, Cardiology
University of California San Francisco, CA, Postdoc, 1977, Cardiovascular Research

Professional Experience

  • 1965-68
    Student trainee, NASA Manned Spacecraft Center, Houston
  • 1969
    Aerospace Engineer, NASA Manned Spacecraft Center, Houston, TX
  • 1977-80
    Assistant Professor of Medicine in Residence, Univ. of California, San Francisco
  • 1981-82
    Associate Professor of Medicine in Residence, Univ. of California, San Francisco
  • 1983-87
    Associate Professor of Medicine, Univ. of California, San Francisco
  • 1987-present
    Professor of Medicine, Univ. of California, San Francisco
  • 2002-present
    Director, UCSF Center for Tobacco Control Research and Education

Honors & Awards

  • (1960)
    Eagle Scout, Bronze Palm
  • (1964)
    Outstanding future teacher
  • (1964)
    Bausch and Lomb Science Award
  • (1968)
    Tau Beta Pi (engineering)
  • (1969-72)
    NSF Graduate Fellowship
  • (1975-77)
    Bay Area Heart Research Committee Senior Research Fellowship
  • (1977-82)
    NIH Research Career Development Award
  • (1978)
    Best Paper Published in Computer
  • (1986)
    Janssen Lecture of Society for Cardiac Anesthesia
  • (1992)
    Fellow, American College of Cardiology
  • (1992-1997)
    Associate Editor, Journal of the American College of Cardiology
  • (1996)
    James Madison Freedom of Information Award, Society of Professional Journalists
  • (1996)
    Alton Ochsner Award of Special Recognition
  • (1997)
    UCSF Chancellor's Award for Public Service
  • (1998)
    American Society of Addiction Medicine Annual Award
  • (1998)
    Gleitsman Foundation Citizen Activist Award
  • (1999)

    American Heart Association Rashkind Lecture
  • (1999)
    "Taking the Heat" Award, University of California Tobacco Related Diseases Research Program
  • (2000)
    Ralph R. Sachs Lecture, UCLA
  • (2000)
    Common Cause Public Service Achievement Award
  • (2000)
    Robert Wood Johnson Innovators in Substance Abuse Control
  • (2002)
    FAMRI Cahan Distinguished Professor Award
  • (2003)
    American Public Health Association, Alcohol and Other Drugs section Lifetime Achievement Award
  • (2005)
    Elected to Institute of Medicine

Selected Publications

  1. Bhatta DN, Hiatt RA, Van Loon K, Glantz SA. Exposure to household tobacco smoke and risk of cancer morbidity and mortality: Analysis of data from the Afghanistan Demographic and Health Survey 2015. Prev Med. 2019 Mar 30.
    View on PubMed
  2. Nguyen KH, Glantz SA, Palmer CN, Schmidt LA. Tobacco industry involvement in children's sugary drinks market. BMJ. 2019 Mar 14; 364:l736.
    View on PubMed
  3. Kulik MC, Glantz SA. Corrigendum to "Similar softening across different racial and ethnic groups of smokers in California as smoking prevalence declined" [Prev. Med. 120 (2019) 144-149]. Prev Med. 2019 Feb 15.
    View on PubMed
  4. Baum A, Aguilar-Gomez S, Lightwood J, Bruzelius E, Glantz SA, Basu S. Estimating the long-run relationship between state cigarette taxes and county life expectancy. Tob Control. 2019 Jan 31.
    View on PubMed
  5. Kulik MC, Glantz SA. Similar softening across different racial and ethnic groups of smokers in California as smoking prevalence declined. Prev Med. 2019 Mar; 120:144-149.
    View on PubMed
  6. Bowling CM, Glantz SA. Conflict of Interest Provisions in State Laws Governing Medical and Adult Use Cannabis. Am J Public Health. 2019 Jan 24; e1-e4.
    View on PubMed
  7. Crosbie E, Bialous S, Glantz SA. Memoranda of understanding: a tobacco industry strategy to undermine illicit tobacco trade policies. Tob Control. 2019 Jan 18.
    View on PubMed
  8. Alzahrani T, Pena I, Temesgen N, Glantz SA. E-cigarettes: Stick to the Evidence. Am J Prev Med. 2019 Jan; 56(1):160-161.
    View on PubMed
  9. Glantz SA. Heated tobacco products: the example of IQOS. Tob Control. 2018 Nov; 27(Suppl 1):s1-s6.
    View on PubMed
  10. Halvorson RT, Stewart CC, Thakur A, Glantz SA. Scientific Quality of Health-Related Articles in Specialty Cannabis and General Newspapers in San Francisco. J Health Commun. 2018; 23(12):993-998.
    View on PubMed
  11. Yang YT, Glantz S. San Francisco Voters End the Sale of Flavored Tobacco Products Despite Strong Industry Opposition. Ann Intern Med. 2018 Nov 20; 169(10):708-709.
    View on PubMed
  12. Lempert LK, Glantz SA. Heated tobacco product regulation under US law and the FCTC. Tob Control. 2018 Nov; 27(Suppl 1):s118-s125.
    View on PubMed
  13. Hiilamo H, Glantz S. Limited implementation of the framework convention on tobacco control's tobacco tax provision: global comparison. BMJ Open. 2018 Oct 02; 8(10):e021340.
    View on PubMed
  14. van der Eijk Y, Bialous S, Glantz SA. Authors' Response. Pediatrics. 2018 Oct; 142(4).
    View on PubMed
  15. Bhatta DN, Glantz S. Parental tobacco use and child death: analysis of data from demographic and health surveys from South and South East Asian countries. Int J Epidemiol. 2018 Oct 01.
    View on PubMed
  16. Bialous SA, Glantz SA. Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control. Tob Control. 2018 Nov; 27(Suppl 1):s111-s117.
    View on PubMed
  17. Popova L, Lempert LK, Glantz SA. Light and mild redux: heated tobacco products' reduced exposure claims are likely to be misunderstood as reduced risk claims. Tob Control. 2018 Nov; 27(Suppl 1):s87-s95.
    View on PubMed
  18. Alzahrani T, Pena I, Temesgen N, Glantz SA. Association Between Electronic Cigarette Use and Myocardial Infarction. Am J Prev Med. 2018 Oct; 55(4):455-461.
    View on PubMed
  19. Glantz SA. PMI's own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes. Tob Control. 2018 Nov; 27(Suppl 1):s9-s12.
    View on PubMed
  20. Ling PM, Glantz SA. Tobacco company strategies to identify and promote the benefits of nicotine. Tob Control. 2018 Aug 09.
    View on PubMed

Go to UCSF Profiles, powered by CTSI